Streetbeat News

Equity Actions

LUNA

Luna Innovations has appointed George Gomez-Quintero as its new Chief Financial Officer (CFO), succeeding Gene Nestro.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 12:37 pm

CSBR

Champions Oncology has announced the appointment of Brady Davis as its new President. The company, listed as CSBR, is expected to benefit from Davis's extensive experience in the healthcare sector.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 12:33 pm

CLRB

Cellectar Biosciences, Inc. (NASDAQ:CLRB) has expanded its commercialization leadership team ahead of the expected readout of top-line pivotal data for iopofosine I 131 in Waldenstrom's macroglobulinemia (WM) in Q4 2023. The company has appointed William Yoon as vice president, medical affairs and Aaditya Nanduri as vice president, business strategy and analytics. Both appointees have been granted a non-qualified inducement stock option to purchase an aggregate of 50,000 shares of Cellectar's common stock.

Portfolio Pulse from Happy Mohamed

October 17, 2023 | 12:21 pm

SOPA

Society Pass Incorporated (NASDAQ:SOPA) has officially launched its digital advertising platform, Thoughtful Media Group Inc (TMG), in the Philippines market. TMG has expanded its ecosystem of multi-platform advertising services through a network of more than 10,000 creators across multiple industries in Southeast Asia. The company is well positioned to benefit from the forecasted increase in digital advertising revenues in the Philippines over the next decade.

Portfolio Pulse from Happy Mohamed

October 17, 2023 | 12:15 pm

BIOX

MLEC

Moolec Science SA (MLEC) has secured a $21M investment from Grupo Insud via a convertible note due 2026. The note will be issued against a cash payment of $10M and in-kind contributions from Insud. This follows Moolec's previous agreement with Bioceres Crop Solutions (BIOX) for the supply of approximately 15,000 tons of HB4® soybeans. The total value of the convertible notes from both deals is approximately $30M.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 12:13 pm

PPBT

Purple Biotech has announced a $5M registered direct offering, which includes around 4.3M American Depositary Shares priced at $1.15 per ADS.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 12:09 pm

PPBT

Purple Biotech has announced a $5 million registered direct offering. This move is expected to provide the company with additional capital for its operations.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 12:08 pm

IQV

Baird analyst Eric Coldwell maintains an Outperform rating on IQVIA Holdings (IQV) and raises the price target from $239 to $248.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 11:52 am

ASMB

GILD

Assembly Bio has entered into a partnership with Gilead, receiving $100M, which includes an upfront payment of $84.8M and a $15.2M equity investment at a premium of 19.9%.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 11:43 am

ASMB

GILD

Gilead Sciences and Assembly Biosciences have announced a 12-year partnership to develop antiviral therapies, initially focusing on herpesviruses, Hepatitis B and D. Assembly Bio will receive a $100M upfront payment.

Portfolio Pulse from Benzinga Newsdesk

October 17, 2023 | 11:41 am